Search

everythinglearnresearchcommunity

for

Search:↓

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Eating 500 fewer calories a day and making lifestyle changes can improve PCOS symptoms and reduce diabetes risk; more research is needed on its causes and treatments.

Myo-inositol may be more effective than metformin for inducing ovulation in women with PCOS.

PCOS is often linked to insulin resistance and obesity, and weight loss can improve symptoms.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

The conclusion is that androgen receptor gene polymorphism might be a marker for polycystic ovary syndrome, but more research is needed.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Women with PCOS, especially those overweight, have higher levels of IL-18 in their endometrium, which may affect fertility.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

VHL disease can cause early paragangliomas, needing lifelong monitoring.

Women with PCOS often have insulin resistance, abnormal lipid levels, and a higher risk of diabetes and heart disease; lifestyle changes and medication like metformin can help manage these risks.

Women with PCOS often have metabolic issues like insulin resistance and a higher risk of diabetes and abnormal lipid levels.

Accurate diagnosis and timely, tailored treatments improve outcomes in obstetrics and gynecology.

Women with hair loss have higher androgen levels, while men with early balding have altered androgen ratios.

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

About 6.5% of young Caucasian women in Spain have polycystic ovary syndrome.

Combining liraglutide and metformin helps obese women with PCOS who didn't lose weight on metformin alone to lose more weight.

Lower SHBG levels may increase the risk of PCOS.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

PCOS in teens is hard to diagnose, linked to genetics and lifestyle, and managed with weight loss and medication.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

The document concludes that treating PCOS requires a combination of drugs to manage reproductive and metabolic symptoms, with more research needed on combination therapies.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

Nonclassic congenital adrenal hyperplasia is a genetic disorder causing hormone imbalances, affecting fertility and requiring personalized treatment.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

Iraqi women with PCOS often have higher testosterone levels and obesity.

Young women with nonclassic congenital adrenal hyperplasia may experience worse sexual function and mild depression compared to healthy women.

A small number of premenopausal female blood donors had high prolactin levels, often due to stress, and retesting is recommended to prevent misdiagnosis.

Blood AMH levels are higher in women with PCOS than in those with other similar conditions.